AtriCure (ATRC) Common Equity (2010 - 2026)
AtriCure (ATRC) posted quarterly Common Equity of $516.4 million for Q2 2026, up 11.18% year-over-year from $464.5 million in Q2 2025, and up 5.03% quarter-over-quarter from $491.7 million in Q1 2026.
AtriCure (ATRC) Common Equity (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has reported Common Equity for 17 consecutive years, with $516.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Common Equity rose 11.18% year-over-year to $516.4 million; the TTM figure through Jun 2026 stood at $516.4 million (up 11.18% YoY), while the FY2025 annual figure was $491.9 million, up 6.72% from the prior year.
- Common Equity advanced to $516.4 million in Q2 2026 per ATRC's latest filing, from $491.7 million in the prior quarter.
- Across five years, Common Equity topped out at $516.4 million in Q2 2026 and bottomed at $450.3 million in Q3 2022.
- Historically, Common Equity has averaged $467.4 million across 5 years, with a median of $462.6 million in 2022.
- On a YoY basis, Common Equity climbed as much as 18.6% in 2022 and fell as far as 7.81% in 2022.
- AtriCure's Common Equity stood at $456.8 million in 2022, then gained by 2.06% to $466.2 million in 2023, then slipped by 1.12% to $461.0 million in 2024, then advanced by 6.72% to $491.9 million in 2025, then increased by 4.98% to $516.4 million in 2026.
- Business Quant data shows ATRC's Common Equity at $516.4 million in Q2 2026, $491.7 million in Q1 2026, and $491.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.47 Bn | 129.26 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 52.21 Bn | 51.35 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.73 Bn | 34.37 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.77 Bn | 32.30 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 28.77 Bn | 26.09 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 24.95 Bn | 24.51 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.32 Bn | 14.92 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.83 Bn | 14.70 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.54 Bn | 11.39 Bn | 1.03 Bn | 6.21 Bn |
| 10 | AtriCure | 2.33 Bn | 2.16 Bn | 118.63 Mn | 516.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 516.43 Mn |
| Mar 31, 2026 | 491.69 Mn |
| Dec 31, 2025 | 491.94 Mn |
| Sep 30, 2025 | 476.51 Mn |
| Jun 30, 2025 | 464.49 Mn |
| Mar 31, 2025 | 454.62 Mn |
| Dec 31, 2024 | 460.97 Mn |
| Sep 30, 2024 | 465.02 Mn |
| Jun 30, 2024 | 462.09 Mn |
| Mar 31, 2024 | 456.31 Mn |
| Dec 31, 2023 | 466.17 Mn |
| Sep 30, 2023 | 462.83 Mn |
| Jun 30, 2023 | 462.42 Mn |
| Mar 31, 2023 | 454.85 Mn |
| Dec 31, 2022 | 456.75 Mn |
| Sep 30, 2022 | 450.31 Mn |
| Jun 30, 2022 | 456.71 Mn |
| Mar 31, 2022 | 462.83 Mn |
| Dec 31, 2021 | 483.76 Mn |
| Sep 30, 2021 | 488.47 Mn |